RxDoctor Payments Data
★ My doctorsLook up a doctor →

Sanjiti Mirmire

Houston, TXNPI 1245975770

Payments from drug & device makers

$3,830in general payments, 2019–2025

Across 163 payments — averaging $23.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$406
  • Genentech USA, Inc.$355
  • UCB, Inc.$350
  • AstraZeneca$327
  • AbbVie$313
  • CSL Behring$298
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$3,827100%
  • Education$30%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis19$406
Genentech USA, Inc.17$355
UCB, Inc.14$350
AstraZeneca(2 entities)12$327
AbbVie16$313
CSL Behring13$298
Acadia Pharmaceuticals Inc12$261
Eisai Inc.8$240
Takeda Pharmaceuticals U.S.A., Inc.8$218
Argenx US, Inc.9$206
SK Life Science, Inc.2$178
Springworks Therapeutics, Inc.7$150
Biogen6$119
Sanofi5$107
Johnson & Johnson(2 entities)4$81
Otsuka America Pharmaceutical, Inc.3$64
Grifols USA, LLC2$43
Tanabe Pharma America, Inc.2$30
Neurelis, Inc.1$23
EMD Serono, Inc.1$21
Biohaven Pharmaceutical Holding Company Ltd.1$20
Amicus Therapeutics, Inc.1$20

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ezetimibe11$63

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →